Nurse Practitioner Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Cori Kellner

Nurse Practitioner, Obstetrics & Gynecology Melbourne, FL Nurse Practitioner

NPI 1376968032 CMS profile 10483726

1223 Gateway Dr, Suite 1D, Melbourne, FL 32901

Open in the dashboard

General payments

$6,194

347 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Cori Kellner of Melbourne, FL is reported in the CMS Open Payments database as having received $6,194 across 347 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Nurse Practitioner, Obstetrics & Gynecology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,307 62
2024 General $1,369 74
2023 General $1,366 86
2022 General $1,170 58
2021 General $982 67

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Cori Kellner
  • Nurse Practitioner, Obstetrics & Gynecology median
  • Middle half of Nurse Practitioner, Obstetrics & Gynecology
  • National median

In program year 2025, general payments to Cori Kellner were reported at $1,307. Among 1,030 Nurse Practitioner, Obstetrics & Gynecology profiles paid that year, the median was $151 and the middle half received between $51 and $371.

Show as a table
Year Cori Kellner Nurse Practitioner, Obstetrics & Gynecology median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $982 $135 $40–$338 $132
2022 $1,170 $143 $45–$386 $149
2023 $1,366 $153 $54–$411 $160
2024 $1,369 $140 $45–$326 $164
2025 $1,307 $151 $51–$371 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Mayne Pharma Inc. $1,076 67 payments
  2. AbbVie, Inc. $844 57 payments
  3. Exeltis, USA Inc. $775 46 payments
  4. Astellas Pharma US Inc $589 26 payments
  5. Sumitomo Pharma America, Inc. $340 13 payments
  6. Hologic, LLC $335 13 payments
  7. Millicent US Inc $335 19 payments
  8. Pfizer Inc. $232 14 payments
  9. Organon LLC $187 8 payments
  10. Currax Pharmaceuticals LLC $177 12 payments
  11. Other $1,303 72 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $6,094 346 payments
  2. Education $100 1 payment
Products named General payments · program years 2021–2025
  1. LO LOESTRIN FE $534 38 payments
  2. ORILISSA $384 22 payments
  3. Veozah $293 14 payments
  4. NEXTSTELLIS $293 22 payments
  5. ORIAHNN $274 17 payments
  6. SLYND Oral contraceptive $241 14 payments
  7. INTRAROSA $239 14 payments
  8. SLYND Contraceptive $233 15 payments
  9. MYFEMBREE $233 9 payments
  10. UBRELVY $204 12 payments
  11. Other $3,883 202 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

347 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner, Obstetrics & Gynecology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record